Overview A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions Status: Withdrawn Trial end date: 2012-02-20 Target enrollment: Participant gender: Summary A study to determine whether a new formulation of methylprednisolone suspension is bioequivalent to methylprednisolone tablets under fed conditions. Phase: Phase 1 Details Lead Sponsor: PfizerTreatments: MethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate